Bibliografia
Abeloff M.D., Armitage J.O., Lichter A.S., et al. Pediatric Tumors. In: Abeloff M.D., Armitage J.O., Lichter A.S., et al. (eds). Clinical Oncology, 2nd edition. Churchill Livingstone, New York, 2000
Alexander F.: Pediatric urologic oncology: Neuroblastoma. Urol Clin North Am, 27(3), 383-392, 2000.
Allegri R.: Padre Pio. L'uomo della speranza. Mondadori, Milano. 1986.
Amati, P., Gasparini, P., Zlotogora, J. et al.: A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22-q23. Am. J. Hum. Genet., 58, 1089–1092, 1996.
Ambros P.F., Brodeur G.M. Concept of tumorigenesis and regression. In: Brodeur G.M., Sawada T., Tsuchida Y.: Neuroblastoma. New York, NY: Elsevier Science, pp 21-32, 2000.
Ayres R.C., Robertson D.A., Dewbury K.C., Millward-Sadler G.H., Smith C.L.: Spontaneous regression of hepatocellular carcinoma. Gut 31, 722–4, 1990.
Beckwith J.B., Perrin E.V.: In situ neuroblastoma: a contribution to the natural history of neural crest tumours. Am J Pathol 43, 1089-1104, 1963.
Bell R., Murday V.A., Patton M.A., Jeffery S.: Two families with blepharophimosis/ptosis/epicanthus inversus syndrome have mutations in the putative forkhead transcription factor FOXL2. Genet. Test. 5 (4): 335-8, 2001.
Beller U., Beckman E.M., Twombly G.H.: Spontaneous regression of advanced endometrial carcinoma. Gynecol Oncol 17(3), 381-5, 1984.
Ben Moualli S., Hajri M., Derouiche A., Chebil M., Ayed M.: Le neuroblastome rétropéritoneal chez l’adulte: à propos d’un cas et revue de la litérature. Ann Urol 35, 51.55, 2001.
Berdon W.E., Ruzal-Shapiro C., Abramson S.J., Garvin J.: The diagnosis of abdominal neuroblastoma: relative roles of ultrasonography, CT, and MRI. Urol Radiol 14(4), 252-262, 1992.
Bernstein ML, et al.: Screening for neuroblastoma in North America: 2-year results from the Quebec Project. American Journal of Pediatric Hematology/Oncology 14(4), 312-319, 1992.
Berthold F., Hunneman D.H., Käser H., et al.: Neuroblastoma screening: Arguments from retrospective analysis of three German neuroblastoma trials. Am J Pediatr Hematol Oncol 13, 8-13, 1991.
Berthold F.: Commentary on Castleberry R.P.: Neuroblastoma. Europ J Cancer 33(9), 1438, 1997.
Besso F., Hashizume K., Nakajo T., Kamoshita S.: Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. Journal of Pediatrics 119, 237-241, 1991.
Blijham G.H., Barlogie B., Richman S., Iatreille J., Welle-Koop L.: Medulloblastoma and neurobastoma in adults. Neth J Med 25, 94-99, 1982.
Bohn M.C.: Division of small intensely fluorescent cells in neonatal rat superior cervical ganglion is inhibited by glucocorticoids. Neuroscience 20(3), 885-894, 1987 1987.
Bown N.: Neuroblastoma tumour genetics: clinical and biological aspects J Clin Pathol 54, 897-910, 2001.
Breslow N, McCann B.: Statistical examination of prognosis for children with neuroblastoma. Cancer Res., 31, 2098-2113, 1971.
Brodeur G.M., Seeger R. C., Barrett A., Berthald F. et al.: International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. Journal of Clinical Oncology 6, 1874-1881, 1980.
Brusa P., Orlandi N.: Simpatoma embrionario benigno plurinodulare sottocutaneo. Riv Neurol 12, 291, 1939.
Burdman J.A., Goldstein M.N.: Long-term tissue culture of neuroblastomas. J. Nat. Cancer Inst. 33, 123-133, 1964.
Cafferata M.A., Chiaramondia M., Monetti F., Ardizzoni A.: Complete spontaneous remission of non-small-cell lung cancer: a case report. Lung Cancer 45(2), 263-6, 2004.
Calabrò M.: Padre Pio a Castel di Iudica. Diario di emozioni. Catania, 2002.
Campbell A., Jack T., Cameron E.: Reticulum cell sarcoma. Two complete “spontaneous” regressions, in response to high dose of ascorbic acid therapy. A report on subsequent progress. Oncol. 48(6), 495-7, 1991.
Carlsen N.L.: How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer. 61(3):441-6, 1990.
Casciano I., Banelli B., Croce M., De Ambrosis A., Di Vinci A., Gelvi I., Pagnan G., Brignole C., Allemanni G., Ferrini S., Ponzoni M., Romani M.: Caspase-8 Gene Expression in Neuroblastoma. Ann. N.Y. Acad. Sci., 35, 1029-1037, 2004.
Castleberry R.P.: Neuroblastoma. Europ J Cancer 33(9), 1430-1438, 1997a.
Castleberry R.P.: Biology and tratment of neuroblastoma. Pediatric Clinics of North America, 44-4, 1997b
Chaudhury A.: Regression of neuroblastoma during pregnancy. Lancet 2(7732), 1041-1042, 1971.
Challis G.B., Stam H.J.: The spontaneous regression of cancer: a review of cases from 1900 to 1987. Acta Oncologica, 29/5, 549 , 1990.
Chauvin F., Mathieu P., Frappaz D., et al: Screening for neuroblastoma in France: Methodological aspects and preliminary observations. Med Pediatr Oncol 28, 81-91, 1997.
Chien R.N., Chen T.J., Liaw Y.F.: Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 87:903–5, 1992.
Coldman A.J., Fryer C.J.H., Elwood J.M., Sonley M.J.: Neuroblastoma: influence of age at diagnosis, stage, tumor site, ad sex on prognosis. Cancer 46, 18961901, 1979.
Cohen M.D., Weetman R., Provisor A., et al.: Magnetic resonance imaging of neuroblastoma with a 0.15-T magnet. Am J Roentgenol 143(6), 1241-1248, 1984.
Cole W.H.: Spontaneous regression of cancer and the importance of finding its cause. Natl Cancer Inst Monogr 44, 5.9, 1976a.
Cole W.H.: Relationship of causative factors in spontaneous regression of cancer to immunologic factors possibly effective in cancer. J Surg Oncol 391–411, 1976b.
Cole W. H.: Efforts to explain spontaneous regression of cancer., J. Surg. Oncol. 17, 201-209, 1981.
Colville H.C.,Willis R.A.: Neuroblastoma metastases in bones, with a criticism of Ewing’s endothelioma. Am. J. Pathol., 9, 421-429, 1933.
Combs S.E, Krieglstein K., Unsicker K.: Reduction of endogenous TGF-beta increases proliferation of developing adrenal chromaffin cells in vivo. J Neurosci Res 59(3), 379-383, 2000.
Comtois R., Bertrand S., Beauregard H., Leger J., Serri O.: Spontaneous regression of prolactin-producing pituitary adenoma during pregnancy. Am J Med 83(5), 1005-1006, 1987.
Connor C.L.: A further consideration of Ewing’s sarcoma. Am J. Cancer, 22, 41-51, 1934.
Copper M.J., Steinberg S.M., Chatten J., Evans A.E., Israel M.A.: Plasticity of neuroblastoma tumour cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival. J Clin Invest 90(6), 2402-2408, 19921992.
Craft A.W, Parker L.: Poor prognosis neuroblastoma: is screening the answer? Br J Cancer 65(suppl), 96-101, 1992.
Craft A.W., Parker L.: Screening for neuroblastoma: 20 years and still no answer. Eur J Cancer 32,1540-1543, 1996.
Crisponi L., Deiana M., Loi A., Chiappe F., Uda M., Amati P., Bisceglia L., Zelante L., Nagaraja R., Porcu S., Ristaldi M.S., Marzella R., Rocchi M., Nicolino M., Lienhardt-Roussie A., Nivelon A., Verloes A., Schlessinger D., Gasparini P., Bonneau D., Cao A., Pilia G. : The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159–166, 2001.
Cushing H., Wolbach S.B.: The transformation of malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. Am J Pathol 3, 203-216, 1927.
Dahlin D.C., Coventry M.B., Scanlow P.W.: Ewing’s sarcoma; a critical analysis of 165 cases. J. Bone Joint Surg, 43-a, 185.192, 1961.
Daneman A., Baunin C., Lobo E., Pracros J.P., Avni F., Toi A., Metreweli C.: Disappearing suprarenal masses in the fetus and neonate Pediatric Radiology 27: 675-681, 1997.
D’Angio G.J., Evans A., Koop C.E.: Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet, I, 1046-1949, 1971.
De Baere E., Dixon M.J., Small K.W., Jabs E.W., Leroy B.P., Devriendt K., Gillerot Y., Mortier G., Meire F., Van Maldergem L. et al. : Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype – phenotype correlation. Hum Mol Genet 10, 1591–1600, 2001.
De Baere E., Beysen D., Oley C., Lorenz B., Cocquet J., De Sutter P., Devriendt K., Dixon M., Fellous M., Fryns J.P., Garza A., Jonsrud C., Koivisto P.A., Krause A., Leroy B.P., Meire F., Plomp A., Van Maldergem L., De Paepe A., Veitia R., Messiaen L.: FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype–phenotype correlation. Am J Hum Genet 72, 478–487, 2003.
Debre R., Lhermitte J., Uhry P., Parris R., Oemichen M.: Tumeur sympathique embryionnaire chez un enfant. Ann Anat Patol (Paris), 15.1, 1938.
Deshmukh M., Johnson E.M.: Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol Pharmacol 51(6), 897-906, 1997.
Doupe A.J., Landis S.C., Patterson P.H.: Environmental influences in the development of neural crest derivatives: glucocorticoids, growth factors, and chromaffin cell plasticity. J Neurosci 5(8), 2119-2142, 1985.
Dreyer Z.E., Fernbach D.J.: Neuroblastoma. In: Johnson K.B., Oski F.A. (eds). Oski's Essential Pediatrics. 1999, Philadelphia: Lippincott-Raven Publishers, pp. 375-376.
Dubois S.G. Kalika Y., Lukens J.N. et al.: Metastatic sites in stage IV and IVs neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 21, 181-189, 1999.
Dunn J.S.: A ganglioneuroma of the sphenomaxillary fossa. Glasgow M.J., 84, 98, 1915.
Dyke P.C., Mulkey D.A.: Maturation of ganglioneuroblastoma to ganglioneuroma. Cancer, 20, 1343-1349, 1967.
Eden K.: The dumb-bell tumors of the spine. Brit. J. Surg. 28, 549-570, 1941.
Eklof O., Sandstedt B., Thonell S., Ahstrom I.: Spontaneous regression of state IV neuroblastoma. Acta Paediatr Scand 72(3), 473-476, 1983.
Enck RE. Spontaneous complete remission in acute promyelocytic leukemia. N Y State J Med 85(11): 662, 1985.
Ernfors P., Ibanez C.F., Ebendal T., et al: Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: Developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87:5454, 1990.
Evans A.E., Gerson J., Schnaufer L.: Spontaneous regression of neuroblastoma. Cancer 20, 1343-1349, 1967.
Evans A.E., D’Angio G.J., Koop C.E.: Diagnosis and treatment of neuroblastoma. Pediatr Clin North Am 23, 161, 1976a.
Evans A.E., Gerson J., Schnaufer L.: Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44, 49-54, 1976b.
Evans A.E., Chatten J., D’Angio G.J., Gerson J.M., Robinson J., Schnaufer L.: A review of 17 IV-S neuroblastoma patients at the Children Hospital of Philadelphia. Cancer, 45, 833-839, 1980.
Evans A.E., D’Angio G.J., Propert K., Anderson J., Hann H.L.: Prognostic factors in Neuroblastoma. Cancer, 59, 1853-1859, 1987.
Everson T.C., Cole W.H. (Eds.): Spontaneous Regression of Cancer. W.B. Saunders, Philadelphia, 1966.
Ewing J.: A review and classification of bone sarcomas. Arch. Surg.., 4, 485-533, 1922.
Farber S.: Neuroblastoma. Am. J. Dis. Child., 60, 749-751, 1940.
Fiori E., Leone G., Gazzanelli S., et al.: Renal cell carcinoma in adolescents. A case report and review of the literature. Panminerva Med 38 (2), 121-8, 1996.
Forman M.S., Trojanowski J.Q., Lee V.M.: Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nature Medicine 10, 1055–1063, 2004.
Fox F., Davidson J., Thomas L.B.: Maturation of sympathicoblastoma into ganglioneuroma. Cancer 12, 108-116, 1959.
Freund P.: Ein Ganglioneurom des rechten Halssympathikus. Frankfurt. Ztschr. f. Path., 13, 266, 1913.
Gaffey M.J., Joyce J.P., Carlson G.S., Esteban J.M.: Spontaneous regression of hepatocellular carcinoma. Cancer 65:2779–83, 1990.
Geschickter C., Copeland M.M.: Tumors of bone (including the jaws and joints). The American Journal of Cancer, New York, Rev. Ed., 381-440, 1936.
Goldstein M.N., Pinkel D.: Longterm tissue culture of neuroblastomas. J. Nat. Cancer Inst. 20, 675-680, 1958.
Grier H.E.: Osteosarcoma. In: Rudolph A.M., Rudolph C.D. (Eds). Rudolph's Pediatrics, 21st edition. McGraw-Hil, New York, 2002.
Griffin M.E., Bolande R.P.: Familial neuroblastoma with regression and maturation to ganglioneurofibroma. Pediatrics 43, 377, 1969.
Guarino M.: Beato impostore. Controstoria di Padre Pio. Kaos edizioni, Milano, 1999.
Gurney J.G., Severson R.K., Davis S., Robison L.L.: Incidence of cancer in children in the United States. Cancer 75, 2186, 1995.
Haas D., Ablin A.R., Miller C., Zoger S., Matthay C.: Complete patologic maturation and regression of Stage IVs neuroblastoma without treatment. Cancer 62, 815-825, 1988.
Haase G.M.: Staging system for neuroblastoma: a look on the old and the new. Pediatr Surg Int 6 14-18, 1991.
Haber S.L., Bennington J.L.: Maturation of congenital extra-adrenal neuroblastoma. Arch. Path. 76, 121-125, 1963.
Hansen P.B.: sympathicoblastoma of the adrenal medulla with osseous metastases. Acta Radiol 40, 500-510, 1953.
Hasegawa R., Tatematsu M., Imaida K., et al.: Neuroblastoma in situ. Acta Pathol Jpn 32(3), 537-546, 1982.
Hasegawa T., Hirose T. , M.D., Ayala A.G., Ito S., Tomaru U., Matsuno Y., Shimoda T., Hirohashi S.: Adult Neuroblastoma of the Retroperitoneum and Abdomen Clinicopathologic Distinction From Primitive Neuroectodermal Tumor. Am J Surg Pathol 25, 918-924, 2001.
Hellström P.A., Malinen L., Malinen H.: Spontaneous remission of bladder neoplasm. Eur J Surg Oncol, 18(5), 521-3, 1992.
Hempstead B.L., Martin-Zanca D., Kaplan D.R., et al: High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350:678, 1991.
Hercbergs A.: Spontaneous remission of cancer. A thyroid hormone dependent phenomenon? Anticancer Res, 19(6A), 4839-44, 1999.
Hicks MJ, Mackay B. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma. Ultrastruct Pathol 19(4): 311-322, 1995.
Hirai M., Yoshida S., Kashiwagi H., Kawamura T., Ishikawa T., Kaneko M., Nakagawara A., Miwa M., Uchida K.: Potential prognostic indicators for the progressive and non-progressive neuroblastomas. Cancer Detection and Prevention 1998; 22 (Supplement 1).
Hiyama E., Hiyama K., Yokoyama T., et al.: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1 (3): 249-55, 1995.
Hiyama E., Reynolds C.P.: Telomerase as a biological and prognostic marker in neuroblastoma. In: Brodeur G.M., Sawada T., Tsuchida Y.: Neuroblastoma. New York, NY: Elsevier Science, pp 159-174, 2000.
Hohn A, Leibrock J, Bailey K, Barde Y-A: Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344:339, 1990.
Holgersen L.O., Subramanian S., Kirpekar M. et al : Spontaneous resolution of antenatally diagnosed adrenal masses. Journal of Pediatric Surgery 31: 153-155, 1996.
Holmes A.S., Klimberg I.W., Stonesifer K.J., Kramer B.S., Wajsman Z.: Spontaneous regression of testicular seminoma: Case report. J Urol 135(4), 795-796, 1986
Huddart S.N., Muir K.R., Parkes S., et al: Neuroblastoma: A 32-year population-based study. Implications for screening. Med Pediatr Oncol 21, 96-102, 1993.
Huston N.: Spontaneous remission of phaeochromocytoma. N Z Med J 101(845): 248, 1988.
Hutter J.J., Doner C., Ghory M.H., et al: Conservative management of unresectable neuroblastoma in infants less than six months of age. Med Pediatr Oncol 23:205, 1994.
Ijiri R., Tanaka Y., Kato K., Misugi K., Nishihira H., Toyoda Y.,Kigasawa H., Nishi T., Takeuchi M., Aida N., Momoi T.: Clinicopathologic Study of Mass-Screened Neuroblastoma With Special Emphasis on Untreated Observed Cases. A Possible Histologic Clue to Tumor Regression. Am J Surg Pathol 24:807-815, 2000.
Ikeda H., Okudaira Y.: Spontaneous regression of pituitary mass in temporal association with pregnancy. Neuroradiology 29(5), 488-492, 1987.
Ikeda Y, Lister J, Bouton JM, Buyukpamukcu M: Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal. J Pediatr Surg 16:636, 1981.
Ikeda M., Okada S., Ueno H., Okusaka T., Kuriyama H.: Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: a Case Report. Japanese Journal of Clinical Oncology 31, 454-458, 2001.
Ikeda Y., Lister J., Bouton J.M., Buyukpamucku M.: Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal. J Pediatr Surg 16(4 suppl 1), 636-644, 1981.
Iwanaka T., Yamamoto K., Ogawa Y., Arai M., Kishimoto H, Hanada R., Imaizumi S.: Maturation of mass-screened localized adrenal neuroblastoma. J Pediatr Surg 36, 1633-1636, 2001.
Iwata M., Koshinaga T., Okabe I., Kurosu Y., Esumi M.: Biological characteristics of neuroblastoma with spontaneous tumor reduction: a case report. J Pediatr Surg 30, 722-723, 1995.
Jennings R.W., LaQuaglia M.P, Leong K., Hendren W.H., Adzick N.S.: Fetal neuroblastoma: prenatal diagnosis and natural history. J Pediatr Surg 28(9), 1168-1174, 1993, 1993.
Joshi V., Cantor A., Altshuler G., et al: Age-linked prognostic categorization base on a new histologic grading of neuroblastoma. Cancer 69, 2197, 1992.
Kappauf H., Gallmeier W. M., Wünsch P. H., Mittelmeier H.O., Birkmann J., Büschel G., Kaiser G., Kraus J.: Complete spontaneous remission in a patient with metastatic non-small-cell lung cancer. Annals of Oncolo gy 8 (10), 1031-1039, 1997.
Kato K., Kato Y., Ijiri R., Misugi K., Nanba I., Nagai J., Nagahara N., Kigasawa H., Toyoda Y., Nishi T., Tanaka Y.: Ewing's sarcoma family of tumor arising in the adrenal gland—Possible diagnostic pitfall in pediatric pathology: Histologic, immunohistochemical, ultrastructural, and molecular study. Hum Pathol 32, 1012-1016, 2001.
Kaye J.A., Warhol M.J., Kretschmar C., Landsberg L., Frei E.: Neuroblastoma in adults. Three case reports and a review of the literature. Cancer 58(5), 1149-1157, 1986.
Kent, J., Coates, T., Pelletier, K., O’Reagan, B.: Unexpected recoveries: spontaneous remission and immune functioning. Advances, 6, 66-73, 1989.
Kerbl R., Urban C.E., Ladenstein R., et al: Neuroblastoma screening in infants postponed after the sixth month of age: A trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features. Med Pediatr Oncol 29, 1-10, 1997.
Kilton L.J., Ashenbrener C., Burns C.P.: Ganglioneuroblastoma in adults. Cancer 37, 974, 1976.
Kissane J.M., Ackerman L.V.: Maturation of tumors of the sympathetic nervous system. J. Facul Radiol 7, 109-114, 1955-1956.
Kitanaka C., Kato K., Ijiri R., et al. Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. J Natl Cancer Inst 94 (5), 358-68, 2002.
Koop C.E., Kiesewetter W.B., Horn R.C.: Neuroblastoma in childhood; An evaluation of surgical management. Pediatrics, 16/5, 652-657, 1955.
Kushner B.H., Cheung N.K.V., La Quaglia M.P., et al: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381, 1996.
Lacquaniti S., Pierconti F., Servello C., Pisanti F., Destito A.: Spontaneous partial fibrotic regression of a primary renal carcinoma: a case report. Arch Ital Urol Androl, 71(1), 35-6, 1999.
Larmande A.M., Delplace M.P., Moraine C., Devlamynck S.: Existence d'une stérilité féminine au cours du syndrome familial ptosis-blépharophimosis-épicanthus. Bull Mem Soc Fr Ophtalmol., 90:257–260, 1978.
Lewison E.F.: Spontaneous regression of breast cancer. Natl Cancer Inst Monogr, 44, 23-6, 1976.
Loffler K.A., Zarkower D., Koopman P.: Etiology of ovarian failure in blepharophimosis-ptosis-epicanthus-inversus syndrome (BPES): FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocrinology, 144, 3237-3243, 2003.
Look A.T., Hayes F.A., Shuster J.J., et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma. A Pediatric Oncology Group Study. J Clin Oncol 9, 581, 1991.
Luosto R., Koikkalainen K., Sipponen P.: Spontaneous regression of a bronchial carcinoid tumor following pregnancy. Ann Chir Gynaecol Fenn 63(4), 342-345, 1974.
Mangel J., Barth D., MacEachren J., Berinstein N.L., Imrie K.R.: Spontaneous Regression of Hodgkin's Disease: Two Case Reports and a Review of the Literature. Hematology 8 (3), 191-196, 2003.
Mangiapan T.: Les guerisons de Lourdes. Etude historique et critique depuis l’origine à nos jours. Édition Oeuvre de la Grote, Lourdes, 1994. Trad. it.: Le guarigioni di Lourdes. Sudio storico e critico dalle origini ai nostri giorni. Edizioni San Paolo, Cinisello Balsamo, 1997.
Markowska J., Markowska A.: Spontaneous tumour regression. Ginekol Pol 69(1): 39-44, 1998.
Martius K.: Maligner Sympathoblastentumor des Halssympathikus, teiweisse ausdifferenziert zu gutartigen Ganglioneurom. Frankfurt. Ztschr. f. Path., 12, 442, 1913.
Mason G.H., Hart-Nercer J., Miller E.J.: Adrenalin-secreting neuroblastoma in an infant. Lancet 1, 2, 322, 1957.
Matsumura M, Tsunoda A., Nishi T., Nishimira H., Sasaki Y.: Spontaneous regression of neuroblastoma detected by mass screening. Lancet 338, 447-448, 1991.
Matthay K.K.: Neuroblastoma: a clinical challenge and a biologic puzzle. Cancer J Clin 45, 179-192, 1995.
Matthay K.K.: Neuroblastoma: Biology and therapy. Oncology 11, 1857-1866, 1997.
McConville C.M., Forsyth J.: Neuroblastoma – a developmental perspective. Cancer Letters 197, 3-9, 2003.
McFarland J., Sappington S.W.: A ganglioneuroma in the neck of a child. Am. J. Pathol., 11, 429-448, 1935.
McLaughlin J.E., Urich H.: Maturing neuroblastoma and ganglioneuroblastoma: a study of four cases with long survival. J Pathol 121, 19, 1977.
Miyauchi J., Kiyotani C., Shioda Y., Kumagai M., Honna T., Matsuoka K., Masaki H., Aiba M., Hata J., Tsunematsu Y.: Unusual chromaffin cell differentiation of a neuroblastoma after chemiotherapy and radiotherapy: report of an autopsy case with immunohistochemical evaluations. Am J Surg Pathol., 28(4):548-53, 204.
Mochizuki T, Takehara Y, Nishimura T, Takahashi M, Kaneko M. Regression of hepatocellular carcinoma. Am J Roentgenol 156:868–9, 1991.
Moraine, C., Titeca, C., Delplace M.-P., Grenier, B., Lenoel, Y., Ribadeau-Dumas, J.L.: Blepharophimosis familial et sterilitè feminine: pleiotropisme ou genes lies? J. Genet. Hum. 24 (suppl.): 125-132, 1976.
Mueh J.R., Greco C.M., Green M.R.: Spontaneous remission of metastatic testicular carcinoma in a patient with bilateral sequential testicular tumour. Cancer 45(11), 2908-2912, 1980.
Murakawa M., Shibuya T., Teshima T., Kudo J., Okamura T., Harada M., Nagafuchi S., Niho Y., Mukae T.: Spontaneous remission from acute exacerbation of chronic adult T-cell leukemia. Blut, 61(6), 346-9, 1990.
Nallathambi J., Moumné L., De Baere E., Beysen D., Usha K., Sundaresan P., Veitia R.A.: A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. Human Genetics, 121, 2007.
Niakan B.: A mechanism of the spontaneous remission and regression of cancer. Cancer Biother Radiopharm 13(3), 209-210, 1998 1998.
Nishihira H., Toyoda Y., Tanaka Y., et al: Natural course of neuroblastoma detected by mass screening: A 5-year prospective study at a single institution. J Clin Oncol 18, 3012-3017, 2000.
Ogata T., Hasegawa T., Tamai S., Sato S., Hasegawa Y., Matsuo N.: Hypergonadotropic Hypogonadism in a 3-Year-Old Girl with Blepharophimosis, Ptosis, and Epicanthus inversus Syndrome. Hormone research, 50, 190-192, 1998.
Ogawa D., Uemura N., Sasaki N., Mukai T., Yamaguchi S., Okamoto S., Yamamoto S., Mashiba H., Taniyama K.: Spontaneous regression of malignant lymphoma of the stomach. J Med. 29(5-6): 381-93, 1998.
Olshan A.F., Bunin G.G.: Epidemiology of neuroblastoma. In Brodeur G.M., Sawada T., Tsuchida Y., Voute P.A. (Eds.): Neuroblastoma. Amsterdam, The Netherlands. Ensevier, 2000, pagg. 33-39.
O’Reagan B., Hirshberg C.: Spontaneous remission bibliography. Institute of Noetic Sciences.1993
Osler W.: The medical aspects of carcinoma of the breast, with a note on the spontaneous disappearance of secondary growth. Amer Med, 13, 17:63, 1901.
Parker L., Craft A.W., Dale G., et al.: Screening for neuroblastoma in the north of England. British Medical Journal 305(6864), 1260-1263, 1992.
Phillips R.: Neuroblastoma. Ann. Roy.Col. Surg. Eng. 12, 29-47, 1953.
Pochedly C.: Neuroblastoma. Acton, Mass., Publishing Sciences Group, 1976.
Powell J.E., Esteve J., Mann J.R., Parker L., Frappaz D., Michaelis J., Kerbl R., Mutz I.D., Stiller C.A.: Neuroblastoma in Europa: differences in the pattern of disease in UK. Lancet, 352, 682-687, 1998.
Pritchard J., Hickman J.A.: Why does stage 4s neuroblastoma regress spontaneously? Lancet 344(8926), 869-70, 1994.
Quirin A.: Beitrag zur kenntnis der embryonalen sympathome. Zentralbl Allg Pathol 32, 184, 1921.
Raile K., Stobbe H., Tröbs R.B., Kiess W.W., Pfäffle R.: A new heterozygous mutation of the FOXL2 gene is associated with a large ovarian cyst and ovarian dysfunction in an adolescent girl with blepharophimosis/ptosis/epicanthus inversus syndrome. European Journal of Endocrinology, Vol 153, Issue 3, 353-358, 2005.
Rangecroft L., Lauder I., Wagget J.: Spontaneous maturation of stage IV-s neuroblastoma. Arch Dis Child 52, 815-817, 1978.
Reynolds C.P., Matthay K.K., Villablanca J.G., Maurer B.J.: Retinoid therapy of high-risk neuroblastoma. Cancer Letters 197, 185-192, 2003.
Rosendal T.: Two cases of sympathicoblastoma of the suprarenal gland with metastasis to the cranium and the tubolar bones. Acta radiol 23, 462-472, 1942.
Ruffo F.: Padre Pio da Pietrelcina. Brancato editore, 2000.
Sato Y, Fujiwara K, Nakagawa S, Kanishima S, Hayashi S, Oka H. A case of spontaneous regression of hepatocellular carcinoma with bone metastasis. Cancer 56:667–71, 1985.
Sawada T.: Past and future of neuroblastoma screening in Japan. Am J Pediatr Hematol Oncol 14, 320-326, 1992.
Schilling F., Claudia S., Berthold F., et al.: Neuroblastoma screening at one year of age. The New England Journal of Medicine. 346, 1047-1053, 2002.
Serpick A.A.: Spontaneous regression of colon carcinoma. Natl Cancer Inst Monogr 44, 21, 1976.
Shimada H., Chatten J., Newton W.A. Jr et al.: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73(2), 405-416, 1984.
Shimada H., Ambros M., Dehner L.P. et al.: Terminology and morphologic criteria of neuroblastic tumors: Recommendation by the International Neuroblastoma Pathology Committee. Cancer, 86, 348-363, 1999.
Siegel S.E., Laug W.E.: Initial urinary catecholamine metabolites and prognosis in neuroblastoma. Pediatrics, 62, 77-87, 1978.
Sofka C.M., Semelka R.C., Kelekis N.L., Worawattanakul S., Chung C.J., Gold S., Fordham L.A.: Magnetic resonance imaging of neuroblastoma using current techniques. Magn Reson Imaging 17(2), 193-198, 1999.
Stark D.D., Moss A.A., Brasch R.C., deLorimier A.A., Albin A.R., London D.A., Gooding C.A.: Neuroblastoma: diagnostic imaging and staging. Radiology 148(1), 101-105, 1983.
Stewart F.W.: Experiences in spontaneous regression of neuroplastic disease in man. Texas Rep. Biol. Med. 10, 239-253, 1952.
Stokes S.H., Thomas P.R.M., Perez C.A., Vietti T.J.: Stage IV-s neuroblastoma. Cancer 53, 2083-2086, 1984.
Stupack D.G., Teitz T., Potter M. D., Mikolon D., Houghton P.J., Kidd V.J., Lahti J.M., Cheresh D.A: Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature, 439, 95-99, 2006.
Suzuki M, Okazaki N, Yoshino M, Yoshida T. Spontaneous regression of a hepatocellular carcinoma. A case report. Hepatogastroenterology 36:160–3, 1989.
Takemura, Osugi, Tokuhara, Kinoshita, Higashino: Case of spontaneous regression of metastatic lesions of leiomyosarcoma of the esophagus. Diseases of the Esophagus 12(4), 317, 1999.
Thiele C.J., Reynolds C.P., IsraelM.J.: Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313, 404-406, 1985.
Thownes P.L., Muechler E.K.: Blefarophimosis, ptosis, epicanthus inversus, and primary amenorrea. A dominat trait. Archives of ophthalmology, 97, 1664-1666, 1979.
Tocci G, Conte A, Guarascio P, Visco G. Spontaneous remission of hepatocellular carcinoma after massive gastrointestinal haemorrhage. Br Med J, 300:641–2, 1990.
Tonini G.P., Mazzocco K., di Vinci A., Geido E., de Bernardi B., Giaretti W.: Evidence of apoptosis in neuroblastoma at onset and relapse. J Neurol Oncol 31, 209-215, 1997.
Toomes, C., Dixon, M.J.: Refinement of a translocation breakpoint associated with blepharophimosis, ptosis epicanthus inversus syndrome to a 280 kb interval at chromosome 3q23. Genomics, 53, 308–314, 1998.
Torres Gómez de Cádiz Silva A., Fernández Nodarse R., Taylor Porter V., Corona Rodríguez P., Longchong Ramos M.: Biopsia de médula ósea. Patrones morfológicos de las hemopatías y tumores sólidos en pediatría. Rev Cubana de Pediatria, Vol. 68, n. 3, 1996.
Trebo M.M., Thorner P.S., Bowman W.P., Weitzman S.: Long-term survival of a stage 4 neuroblastoma patient despite persistent bone marrow disease following autologous bone marrow transplantation. Medical and Pediatric Oncology, 33, 585 – 587, 1999.
Treuner J., Schilling F.H.: Neuroblastoma mass screening: the arguments for and against. Europ J Cancer, 31A(4), 565-568, 1995.
Triche T.J., Ross W.G.: Glycogen-containing neuroblastoma with clinical and hystological features of Ewing’s sarcoma. Cancer 41, 1425-1432, 1978.
Triche T.J., Askin F.B.: Neuroblastoma and the differential diagnosis of small- round blue-cell tumors. Hum Pathol 14, 569-595, 1983.
Tuchman M., Lemieux B., Auray-Blais C., et al: Screening for neuroblastoma at 3 weeks of age: Methods and preliminary results from the Quebec neuroblastoma screening project. Pediatrics 86, 765-773, 1990.
Tucker G.R.: Adrenocorticotropic hormone in the aetiology and regression of neuroblastoma. Medical Hypotheses 59(2), 117-128, 2002.
Turkel S.B., Itabashi H.H.: The natural history of neuroblastic cells in the fetal adrenal gland. Am J Pathol 76(2), 225-244, 1974.
Uchino J., Hata Y., Kasai Y.: Stage IVs neuroblastoma. J Pediatr Surg 13, 167-172. 1978.
Uhlmann E.M., von Essen C.: Neuroblastoma-Neuroblastoma sympatheticum. Pediatrics 15, 402-411, 1955 1955.
Uda M., Ottolenghi C., Crisponi L., Garcia J.E., Deiana M., Kimber W., Forabosco A, Cao A., Schlessinger D., Pilia G.: Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Human Molecular Genetics, 13, 1171-1181, 2004.
van Halteren HK, et al.: Spontaneous regression of hepatocellular carcinoma. J Hepatol, 1997.
Vignes: Epicanthus hereditaire. Rev. Gen. Opthal. 8: 438, 1889.
Visfeldt J.: Transformation of sympathycoblastoma into ganglioneuroma. Acta Path Microbiol Scand 58, 414-428, 1963.
Wahl H.R., Craig P.E.: Multiple tumors of the sympathetic nervous system; report of case showing a distinct ganglioneuroma, neuroblastoma and cystic calcifyng ganglioneuroblstoma. Am. J. Pathol., 14, 797-808, 1938.
Watkins W.J., Harris S.E., Craven M.J., Vincent A.L., Winship I.M., Gersak K., Shelling A.N.: An investigation into FOXE1 polyalanine tract length in premature ovarian failure. Molecular Human Reproduction, (3):145-149, 2006.
White P.S., Thompson P.M., Seigfried B.A. et al.: Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol 36, 37-41, 2001.
Wiernik P.H.: Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr, 44, 35-8, 1976.
Willis R.A.: Metastatic neuroblastoma in bone presenting the Ewing sindrome, with a discussion of Ewing’s sarcoma”. Am. J. Pathol., 16, 317-331, 1940.
Winowska M.: Il vero volto di Padre Pio. San Paolo, Cinisello Balsamo (MI), 1988.
Wittenborg M.H.: Roentgen therapy in neuroblastoma. A review of seventhy-three cases. Radiology, 54, 679-688, 1950.
Woods W.G., Tuchman M., Robison L.L. et al.: A population-based study of the usefullness of screening for neuroblastoma. Lancet 348, 1682-1687, 1996.
Woods W., Gao R., Shuster J., et al.: Screening of infants and mortality due to neuroblastoma. The New England Journal of Medicine. 346, 1041-1046, 2002.
Wyatt G.M.: Abstract of discussion of Wyatt G.M. and Farber S.: Neuroblastoma sympatheticum. Am. J. Roentgen. 46, 485-496, 1941.
Yamamoto K., Hanada R., Kikuchi A. et al.: Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 16, 1265-1269, 1998.
Yamamoto K, Ohta S, Ito E, et al. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J Clin Oncol 20 (5), 1209-14, 2002.
Yoneda A., Oue T., Imura K. Et al.: Observation of untreated patients with neuroblastoma detected by mass screening: A “wait and see” pilot study. Med Pediatr Oncol 36, 160-162, 2001.
Yunis E.J., Walpusk J.A., Agostini R.M. et al.: Glycogen in neuroblastomas. Am J Surg Patol 3, 313, 1979.
Zlotogora J., Sagi M., Cohen T.: The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet., 35(5): 1020–1027, 1983.